{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:45:08Z","timestamp":1790700308279,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":832,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jpain.2020.12.006","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T09:56:32Z","timestamp":1610445392000},"page":"692-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist"],"prefix":"10.1016","volume":"22","author":[{"given":"Juliet","family":"Mwirigi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9534-9306","authenticated-orcid":false,"given":"Moeno","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayne N.","family":"Hassler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1125-739X","authenticated-orcid":false,"given":"Ayesha","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradipta R.","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4730-8988","authenticated-orcid":false,"given":"Changyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Chamessian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakleh","family":"Mseeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breya P.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2602-023X","authenticated-orcid":false,"given":"Marvin T.","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Van de Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Rong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Dussor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Boitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Vagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore J.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.jpain.2020.12.006_bib0001","first-page":"S21","article-title":"Collaborators C: The concise guide to pharmacology 2019\/20: G protein-coupled receptors","volume":"176","author":"Alexander","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2020.12.006_bib0002","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1523\/JNEUROSCI.20-12-04680.2000","article-title":"Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C","volume":"20","author":"Aley","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2020.12.006_bib0003","doi-asserted-by":"crossref","first-page":"e55740","DOI":"10.1371\/journal.pone.0055740","article-title":"Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets","volume":"8","author":"Arachiche","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2020.12.006_bib0004","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1021\/jm1013049","article-title":"Potent agonists of the protease activated receptor 2 (PAR2)","volume":"54","author":"Boitano","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpain.2020.12.006_bib0005","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1365-2982.2009.01373.x","article-title":"PAR4: A new role in the modulation of visceral nociception","volume":"21","author":"Bradesi","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jpain.2020.12.006_bib0006","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1160\/TH03-04-0203","article-title":"Evidence for functionally active protease-activated receptor-3 (PAR-3) in human vascular smooth muscle cells","volume":"90","author":"Bretschneider","year":"2003","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.jpain.2020.12.006_bib0007","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2006-939553","article-title":"Protease-activated receptors: How proteases signal to cells to cause inflammation and pain","volume":"32","author":"Bunnett","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jpain.2020.12.006_bib0008","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jpain.2020.12.006_bib0009","doi-asserted-by":"crossref","first-page":"6809","DOI":"10.1038\/s41598-018-25110-7","article-title":"Transcriptional profiling of somatostatin interneurons in the spinal dorsal horn","volume":"8","author":"Chamessian","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpain.2020.12.006_bib0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.jpain.2020.12.006_bib0011","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-6147(99)01440-6","article-title":"Protease-activated receptors: sentries for inflammation?","volume":"21","author":"Cocks","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jpain.2020.12.006_bib0012","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2002-08-2497","article-title":"Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells","volume":"102","author":"Colognato","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2020.12.006_bib0013","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/35025229","article-title":"Thrombin signalling and protease-activated receptors","volume":"407","author":"Coughlin","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jpain.2020.12.006_bib0014","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1050-1738(99)00005-5","article-title":"Proteolytically activated receptor-3. A member of an emerging gene family of protease receptors expressed on vascular endothelial cells and platelets","volume":"9","author":"Cupit","year":"1999","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jpain.2020.12.006_bib0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jpain.2020.12.006_bib0016","doi-asserted-by":"crossref","first-page":"19076","DOI":"10.1074\/jbc.M110.185264","article-title":"The protease-activated receptor-2-specific agonists 2-aminothiazol-4-yl-LIGRL-NH2 and 6-aminonicotinyl-LIGRL-NH2 stimulate multiple signaling pathways to induce physiological responses in vitro and in vivo","volume":"286","author":"Flynn","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpain.2020.12.006_bib0017","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1096\/fj.12-217323","article-title":"Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tethering","volume":"27","author":"Flynn","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.jpain.2020.12.006_bib0018","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-8794-3-21","article-title":"SEURAT: Visual analytics for the integrated analysis of microarray data","volume":"3","author":"Gribov","year":"2010","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jpain.2020.12.006_bib0019","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-pharmtox-011613-140016","article-title":"Challenges and opportunities in protease-activated receptor drug development","volume":"57","author":"Hamilton","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jpain.2020.12.006_bib0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nn.3289","article-title":"A subpopulation of nociceptors specifically linked to itch","volume":"16","author":"Han","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jpain.2020.12.006_bib0021","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood.2019004634","article-title":"PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153","volume":"136","author":"Han","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2020.12.006_bib0022","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2567.2004.01870.x","article-title":"Tethered ligand-derived peptides of proteinase-activated receptor 3 (PAR3) activate PAR1 and PAR2 in Jurkat T cells","volume":"112","author":"Hansen","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.jpain.2020.12.006_bib0023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2020.12.006_bib0024","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0333102418779548","article-title":"Protease activated receptor 2 (PAR2) activation causes migraine-like pain behaviors in mice","volume":"39","author":"Hassler","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jpain.2020.12.006_bib0025","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137393","article-title":"The cellular basis of protease activated receptor type 2 (PAR2) evoked mechanical and affective pain","author":"Hassler","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jpain.2020.12.006_bib0026","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12959-019-0194-8","article-title":"Protease-activated receptors (PARs): Mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases","volume":"17","author":"Heuberger","year":"2019","journal-title":"Thromb J"},{"key":"10.1016\/j.jpain.2020.12.006_bib0027","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/gutjnl-2017-315631","article-title":"Single-cell RNAseq reveals seven classes of colonic sensory neuron","volume":"68","author":"Hockley","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jpain.2020.12.006_bib0028","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/bph.12544","article-title":"Biased signalling and proteinase-activated receptors (PARs): Targeting inflammatory disease","volume":"171","author":"Hollenberg","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2020.12.006_bib0029","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neuron.2007.07.008","article-title":"Signaling pathways in sensitization: Toward a nociceptor cell biology","volume":"55","author":"Hucho","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.jpain.2020.12.006_bib0030","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/386502a0","article-title":"Protease-activated receptor 3 is a second thrombin receptor in humans","volume":"386","author":"Ishihara","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jpain.2020.12.006_bib0031","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1182\/blood.V91.11.4152","article-title":"Antibodies to protease-activated receptor 3 inhibit activation of mouse platelets by thrombin","volume":"91","author":"Ishihara","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jpain.2020.12.006_bib0032","doi-asserted-by":"crossref","first-page":"E7438","DOI":"10.1073\/pnas.1721891115","article-title":"Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome","volume":"115","author":"Jimenez-Vargas","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpain.2020.12.006_bib0033","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molimm.2012.12.021","article-title":"Expression, function and cooperating partners of protease-activated receptor type 3 in vascular endothelial cells and B lymphocytes studied with specific monoclonal antibody","volume":"54","author":"Kalashnyk","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jpain.2020.12.006_bib0034","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-662-46450-2_2","article-title":"The pharmacology of nociceptor priming","volume":"227","author":"Kandasamy","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.jpain.2020.12.006_bib0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.regpep.2004.07.032","article-title":"Proteinase-activated receptors (PARs)\u2013the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1","volume":"125","author":"Kaufmann","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.jpain.2020.12.006_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152055","article-title":"Protease-activated receptor 4 induces bladder pain through high mobility group Box-1","volume":"11","author":"Kouzoukas","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jpain.2020.12.006_bib0037","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41467-018-03751-6","article-title":"Massive mining of publicly available RNA-seq data from human and mouse","volume":"9","author":"Lachmann","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jpain.2020.12.006_bib0038","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pain.2010.02.010","article-title":"Serine proteases and protease-activated receptor 2-dependent allodynia: A novel cancer pain pathway","volume":"149","author":"Lam","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2020.12.006_bib0039","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nmeth.1455","article-title":"Coding of facial expressions of pain in the laboratory mouse","volume":"7","author":"Langford","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.jpain.2020.12.006_bib0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/cr.2015.149","article-title":"Somatosensory neuron types identified by high-coverage single-cell RNA-sequencing and functional heterogeneity","volume":"26","author":"Li","year":"2016","journal-title":"Cell Res"},{"key":"10.1016\/j.jpain.2020.12.006_bib0041","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0031-6997(24)01493-5","article-title":"Proteinase-activated receptors","volume":"53","author":"Macfarlane","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jpain.2020.12.006_bib0042","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1073\/pnas.0700763104","article-title":"Protease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization","volume":"104","author":"McLaughlin","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpain.2020.12.006_bib0043","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-genet-120116-024723","article-title":"Mas-related G protein-coupled receptors and the biology of itch sensation","volume":"51","author":"Meixiong","year":"2017","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.jpain.2020.12.006_bib0044","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1126\/science.1233765","article-title":"The cells and circuitry for itch responses in mice","volume":"340","author":"Mishra","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jpain.2020.12.006_bib0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuron.2018.10.019","article-title":"Uncovering the cells and circuits of touch in normal and pathological settings","volume":"100","author":"Moehring","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.jpain.2020.12.006_bib0046","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1523\/JNEUROSCI.0220-17.2017","article-title":"The MNK-eIF4E signaling axis contributes to injury-induced nociceptive plasticity and the development of chronic pain","volume":"37","author":"Moy","year":"2017","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpain.2020.12.006_bib0047","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/35007085","article-title":"PAR3 is a cofactor for PAR4 activation by thrombin","volume":"404","author":"Nakanishi-Matsui","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jpain.2020.12.006_bib0048","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s00018-008-7555-y","article-title":"The protease-activated receptor-3 (PAR-3) can signal autonomously to induce interleukin-8 release","volume":"65","author":"Ostrowska","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jpain.2020.12.006_bib0049","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pain.2004.10.021","article-title":"Chronic hyperalgesic priming in the rat involves a novel interaction between cAMP and PKCepsilon second messenger pathways","volume":"113","author":"Parada","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2020.12.006_bib0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/bs.pmbts.2014.11.010","article-title":"Commonalities between pain and memory mechanisms and their meaning for understanding chronic pain","volume":"131","author":"Price","year":"2015","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"Suppl 1","key":"10.1016\/j.jpain.2020.12.006_bib0051","first-page":"S263","article-title":"Proteinases and signalling: Pathophysiological and therapeutic implications via PARs and more","volume":"153","author":"Ramachandran","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jpain.2020.12.006_bib0052","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tins.2009.07.007","article-title":"Critical role of nociceptor plasticity in chronic pain","volume":"32","author":"Reichling","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jpain.2020.12.006_bib0053","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/mol.111.072850","article-title":"Regulation of human vascular protease-activated receptor-3 through mRNA stabilization and the transcription factor nuclear factor of activated T cells (NFAT)","volume":"80","author":"Rosenkranz","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jpain.2020.12.006_bib0054","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00011-009-8087-0","article-title":"Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation","volume":"58","author":"Russell","year":"2009","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jpain.2020.12.006_bib0055","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1074\/jbc.273.24.15061","article-title":"The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a Par gene cluster and characterization in vascular endothelial cells and platelets","volume":"273","author":"Schmidt","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpain.2020.12.006_bib0056","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2003-0025","article-title":"Proteinase-activated receptors: Transducers of proteinase-mediated signaling in inflammation and immune response","volume":"26","author":"Steinhoff","year":"2005","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jpain.2020.12.006_bib0057","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/j.pain.0000000000000125","article-title":"Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state","volume":"156","author":"Tillu","year":"2015","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2020.12.006_bib0058","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/89945","article-title":"Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway","volume":"7","author":"Vergnolle","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jpain.2020.12.006_bib0059","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pharmthera.2009.05.004","article-title":"Protease-activated receptors as drug targets in inflammation and pain","volume":"123","author":"Vergnolle","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jpain.2020.12.006_bib0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/glia.10012","article-title":"Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling","volume":"37","author":"Wang","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.jpain.2020.12.006_bib0061","doi-asserted-by":"crossref","first-page":"F1077","DOI":"10.1152\/ajprenal.00526.2017","article-title":"Endogenous H2S sensitizes PAR4-induced bladder pain","volume":"314","author":"Wang","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jpain.2020.12.006_bib0062","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw6471","article-title":"Anti-PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates","volume":"12","author":"Wang","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jpain.2020.12.006_bib0063","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1097\/j.pain.0000000000001866","article-title":"Pharmacological target-focused transcriptomic analysis of native vs cultured human and mouse dorsal root ganglia","volume":"161","author":"Wangzhou","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2020.12.006_bib0064","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1541-7786.MCR-10-0019","article-title":"Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: Distinct role of PAR1 and PAR3 signaling","volume":"8","author":"Wysoczynski","year":"2010","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jpain.2020.12.006_bib0065","doi-asserted-by":"crossref","first-page":"13875","DOI":"10.1074\/jbc.M115.642736","article-title":"Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to cause inflammation and pain","volume":"290","author":"Zhao","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpain.2020.12.006_bib0066","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.brainres.2005.02.018","article-title":"Expression of mRNA for four subtypes of the proteinase-activated receptor in rat dorsal root ganglia","volume":"1041","author":"Zhu","year":"2005","journal-title":"Brain Res"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590021000018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590021000018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:04:09Z","timestamp":1761509049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590021000018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1526590021000018"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2020.12.006","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.07.08.194373","asserted-by":"object"}]},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2020.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by United States Association for the Study of Pain, Inc.","name":"copyright","label":"Copyright"}]}}